|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-10-11
|
|
pubmed:abstractText |
Endothelial progenitor cells (EPC) are involved in the process of endothelial maintenance and angiogenesis and might be related to endothelial function. EPC function was shown to be impaired in type 2 diabetic patients. Since endothelial dysfunction of type 2 diabetic patients can be ameliorated by treatment with thiazolidinediones we asked whether this treatment might also influence number and function of EPC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AC133 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/acetyl-LDL,
http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0021-9150
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
183
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
163-7
|
|
pubmed:meshHeading |
pubmed-meshheading:15907852-Antigens, CD,
pubmed-meshheading:15907852-Antigens, CD34,
pubmed-meshheading:15907852-Cell Count,
pubmed-meshheading:15907852-Cell Division,
pubmed-meshheading:15907852-Cell Movement,
pubmed-meshheading:15907852-Cells, Cultured,
pubmed-meshheading:15907852-Cholesterol,
pubmed-meshheading:15907852-Diabetes Mellitus, Type 2,
pubmed-meshheading:15907852-Endothelial Cells,
pubmed-meshheading:15907852-Endothelium, Vascular,
pubmed-meshheading:15907852-Female,
pubmed-meshheading:15907852-Glucose Clamp Technique,
pubmed-meshheading:15907852-Glycoproteins,
pubmed-meshheading:15907852-Hemoglobin A, Glycosylated,
pubmed-meshheading:15907852-Humans,
pubmed-meshheading:15907852-Hyperinsulinism,
pubmed-meshheading:15907852-Insulin Resistance,
pubmed-meshheading:15907852-Lipoproteins, LDL,
pubmed-meshheading:15907852-Male,
pubmed-meshheading:15907852-Middle Aged,
pubmed-meshheading:15907852-Monocytes,
pubmed-meshheading:15907852-PPAR gamma,
pubmed-meshheading:15907852-Peptides,
pubmed-meshheading:15907852-Single-Blind Method,
pubmed-meshheading:15907852-Thiazolidinediones,
pubmed-meshheading:15907852-Triglycerides,
pubmed-meshheading:15907852-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells.
|
|
pubmed:affiliation |
Nephrology, Department of Medicine, University Hospital Dresden, Fetscherstrasse 74, Dresden 01307, Germany. frankpistrosch@hotmail.com
|
|
pubmed:publicationType |
Journal Article
|
